Skip to main content
Alzheimer's & Dementia logoLink to Alzheimer's & Dementia
. 2025 Jan 3;20(Suppl 1):e087301. doi: 10.1002/alz.087301

Functional connectivity associations with markers of disease progression in GRN mutation carriers

Taru M Flagan 1, Stephanie A Chu 1, Suvi Häkkinen 1, Liwen Zhang 1, David McFall 1, Carolin Heller 2, Jonathan D Rohrer 3, Jesse A Brown 1, Alex Jihun Lee 1, Kristen Fernhoff 1, Lorenzo Pasquini 1, Maria Luisa Mandelli 4, Maria Luisa Gorno Tempini 5, Jennifer S Yokoyama 1, Virginia Sturm 6, Brian Appleby 7, Brad C Dickerson 8, Kimiko Domoto‐Reilly 9, Tatiana M Foroud 10, Daniel H Geschwind 11, Nupur Ghoshal 12, Neill R Graff‐Radford 13, Murray Grossman 14, Ging‐Yuek Robin Hsiung 15, Eric J Huang 6, Edward D Huey 16, Kejal Kantarci 17, Anna M Karydas 1, Daniel Kaufer 18, David S Knopman 19, Irene Litvan 20, Ian R MacKenzie 21, Mario F Mendez 22, Chiadi U Onyike 23, Leonard Petrucelli 24, Eliana Marisa Ramos 25, Erik D Roberson 26, Julio C Rojas 27, Maria Carmela Tartaglia 28, Arthur W Toga 29, Sandra Weintraub 30, Leah K Forsberg 31, Hilary W Heuer 5, Brad F Boeve 31, Adam L Boxer 5, Howard J Rosen 32, Bruce L Miller 4, Fermin Moreno 33, William W Seeley 34, Suzee E Lee 1,; the ARTFL/LEFFTDS Consortia
PMCID: PMC11709522

Abstract

Background

Autosomal dominant progranulin (GRN) mutations are a common genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression. We previously showed that presymptomatic GRN carriers exhibit thalamocortical hyperconnectivity that increases with age when they are presumably closer to symptom onset. However, whether hyperconnectivity arises concomitantly with markers of neurodegeneration remains unclear.

Method

Utilizing T1 and task‐free functional magnetic resonance imaging (tf‐fMRI) from 49 presymptomatic and 26 symptomatic GRN mutation carriers, we determined the relationships between functional connectivity as measured by voxel‐wise whole brain degree and GRN‐relevant markers of disease progression, which included plasma neurofilament light chain (NfL) concentrations, CSF complement C1q and C3b protein levels, grey matter atrophy, and OCD symptom severity.

Result

NfL concentrations were associated with frontotemporoparietal and thalamic hyperconnectivity in presymptomatic GRN carriers and extensive regions of atrophy in symptomatic carriers. Complement levels were associated with regions of hyperconnectivity, but not gray matter, in symptomatic carriers. Presymptomatic carriers with thalamic hyperconnectivity tended to have lower grey matter volume in bilateral insula and left lateral parietal cortex, which are among regions that deteriorate in GRN‐FTD. OCD symptom severity was associated with hypoconnectivity across all GRN carriers.

Conclusion

In presymptomatic carriers, the co‐occurrence of hyperconnectivity, high NfL, and low gray matter suggests that tf‐fMRI hyperconnectivity may portend the onset of the neurodegenerative phase. These findings point toward hyperconnectivity as an indicator of approaching symptomatic onset.


Articles from Alzheimer's & Dementia are provided here courtesy of Wiley

RESOURCES